Keywords: pfizer, eps, 4th, qtr, rises, announced, fourth-quarter
Pfizer EPS in 4th qtr rises 56%
Article | 18 January 2000
Pfizer has announced fourth-quarter 1999 revenues of $4.50 billion, anincrease of 17% over the like, year-earlier period, while net income rose 50% to $954 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
